A 45-year-old man with newly diagnosed disseminated intravascular coagulation (DIC) secondary to sepsis presents with bleeding from multiple sites. What is the drug of choice for initial management of the bleeding manifestations in DIC?

Explanation

## Disseminated Intravascular Coagulation (DIC) Management **Key Point:** DIC is a life-threatening condition characterized by systemic activation of coagulation, leading to consumption of platelets and clotting factors, and paradoxically both thrombosis and bleeding. Management focuses on treating the underlying cause and replacing consumed coagulation factors. ### Pathophysiology of DIC ```mermaid flowchart TD A[Sepsis/Infection/Trauma]:::urgent --> B[Tissue Factor Release]:::outcome B --> C[Thrombin Generation]:::outcome C --> D[Platelet Consumption]:::urgent C --> E[Fibrin Deposition]:::urgent D --> F[Thrombocytopenia]:::outcome E --> G[Microthrombi]:::outcome C --> H[Fibrinogen Depletion]:::urgent H --> I[Bleeding Manifestations]:::urgent I --> J[Fresh Frozen Plasma + Platelet Transfusion]:::action K[Treat Underlying Cause]:::action --> L[Control DIC]:::outcome ``` ### Management Strategy in DIC **High-Yield:** Fresh frozen plasma (FFP) is the first-line replacement therapy for DIC-associated bleeding because it contains all vitamin K-dependent factors (II, VII, IX, X), fibrinogen, and other coagulation proteins that are consumed in DIC. | Intervention | Mechanism | Role in DIC | |--------------|-----------|-------------| | **Fresh Frozen Plasma** | Contains all coagulation factors, fibrinogen, platelets (no) | **First-line** for factor replacement and fibrinogen replenishment | | Cryoprecipitate | Contains fibrinogen, Factor VIII, von Willebrand factor, fibronectin | Adjunctive for severe hypofibrinogenemia (< 100 mg/dL) | | Platelet Transfusion | Platelet concentrate | For thrombocytopenia (< 50,000/μL) | | Anticoagulation (Heparin) | Inhibits thrombin generation | Controversial; used only if thrombosis predominates | | Aspirin | Antiplatelet | **Not indicated** in DIC; worsens bleeding | | Warfarin | Vitamin K antagonist | **Contraindicated** in acute DIC | ### Clinical Pearl **Clinical Pearl:** The cornerstone of DIC management is treating the underlying cause (e.g., antibiotics for sepsis, source control for infection). Supportive transfusion therapy with FFP and platelets is essential, but anticoagulation (heparin) is reserved for cases where thrombosis predominates and is controversial even then. **Mnemonic — DIC Management: TREAT** - **T**reat underlying cause (sepsis, malignancy, trauma) - **R**eplace coagulation factors (FFP) - **E**nhance platelet count (platelet transfusion) - **A**void anticoagulation unless thrombosis predominates - **T**ransfer to ICU for monitoring **Warning:** Aspirin and other antiplatelet agents are contraindicated in DIC because they impair platelet function and worsen bleeding. Warfarin is also contraindicated in acute DIC because it further depletes vitamin K-dependent factors. Anticoagulation with heparin is used only in rare cases where thrombosis is the dominant manifestation, not bleeding. **Tip:** FFP is preferred over prothrombin complex concentrate (PCC) in DIC because DIC involves consumption of multiple coagulation factors, not just vitamin K deficiency. PCC is indicated for vitamin K deficiency or warfarin reversal, not DIC.